echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Changchun Haiyue Hedara fofi first imitation approved by the State Bureau for listing

    Changchun Haiyue Hedara fofi first imitation approved by the State Bureau for listing

    • Last Update: 2020-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On February 17,, the State Administration announced the approval of theDrug(http://, and Changchun Haiyue Tadalajara was approved for the first timeChangchun Hyatt Pharmaceuticals declared production on July 10, 2017, was included in the priority review by CDE on November 22, 2017, was approved for market in February 2019, the drug is declared in accordance with the new category 4, this adoption also means that the adoption of a consistent evaluation as appropriatedrug(http://Tadalafi, the trade name: Cialis, a long-acting phosphoelseerase 5 (PDE5) inhibitor developed by Lilly to treat erectile dysfunction (ED) in menListed in the U.Sin 2003, global sales were $2.456 billion in 2016 and $2.304 billion in 2017According to the data, in 2017, total sales of Hedarafi exceeded 700 million yuan in China's urban public hospitals, county-level public hospitals, urban community centers, township hospitals (China's publicmedical(http://institutions) terminals and China's urban retail pharmacies terminal chemicals market
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.